UTAH MEDICAL PRODUCTS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent of 0.25% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther · last filed 2026-03-27
- UTAH MEDICAL PRODUCTS, INC. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2025 was 0.25%.
- UTAH MEDICAL PRODUCTS, INC. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2023 was 0.29%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month |
|---|---|---|
| 2025-12-31 | 0.25% 10-K · filed 2026-03-27 | |
| 2024-12-31 | 0.23% 10-K · filed 2026-03-27 | |
| 2023-12-31 | 0.29% 10-K · filed 2026-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |